Advances in Nanotechnology for Enhanced Leukemia Therapy: A Systematic Review of In Vivo Studies
Journal of Lab Animal Research · 2023
DOI: 10.58803/jlar.v2i6.34 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Lab Animal Research, 2023. Verfasst von Ahmad Mir Hosseini und 6 weiteren Autor:innen. Die Arbeit nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objective: Leukemia, a heterogeneous group of blood cancers, can present a significant clinical challenge due to its varying subtypes and complexity. The application of nanotechnology has the potential to revolutionize the treatment of leukemia. Based on in vivo studies, this systematic review provides an accurate and current assessment of nanotechnology therapeutic advances in leukemia treatment.
Methods
The present systematic review focused on in vivo studies investigating nanotechnology's therapeutic potential for leukemia treatment. Comprehensive searches were conducted across leading databases, including PubMed, Scopus, and Google Scholar, to identify relevant publications. Selection criteria encompassed studies that employed animal models to assess nanotechnology effects on leukemia progression. Data extracted from selected articles were rigorously analyzed. This review included studies published between 2010 and 2022.
Results
Based on the inclusion criteria, 24 relevant studies were identified. According to the findings of this review, nanotechnology has made substantial progress in the treatment of leukemia, as demonstrated by in vivo studies. Advanced nanoparticle-based drug delivery systems, precision gene therapies, and targeted therapeutic approaches have consistently exhibited superior outcomes in treating various leukemia subtypes in animal models. These compelling results emphasize the transformative potential of nanotechnology for leukemia therapy.
Conclusion
In conclusion, the meticulous analyses of the in vivo studies underscore the role that nanotechnology plays in the advancement of the treatment of leukemia. Nanotechnology has demonstrated efficacy in preclinical models, indicating that it can be translated into clinical applications, offering new avenues for treating leukemia and reinforcing its position as an innovative therapeutic approach.
Zitieren
APA
Hosseini, A. M., Dianaty, S., Shahhosseini, S., Biglarifard, R., Razmi, R., Komeili, N., & Soltani, D. (2023). Advances in Nanotechnology for Enhanced Leukemia Therapy: A Systematic Review of In Vivo Studies. Journal of Lab Animal Research. https://doi.org/10.58803/jlar.v2i6.34
Vancouver
Hosseini AM, Dianaty S, Shahhosseini S, Biglarifard R, Razmi R, Komeili N, et al. Advances in Nanotechnology for Enhanced Leukemia Therapy: A Systematic Review of In Vivo Studies. Journal of Lab Animal Research. 2023. doi:10.58803/jlar.v2i6.34
BibTeX
@article{Hosseini2023,
author = {Hosseini, Ahmad Mir and Dianaty, Shiva and Shahhosseini, Sara and Biglarifard, Reza and Razmi, Razieh and Komeili, Nima and Soltani, Danial},
title = {Advances in Nanotechnology for Enhanced Leukemia Therapy: A Systematic Review of In Vivo Studies},
journal = {Journal of Lab Animal Research},
year = {2023},
doi = {10.58803/jlar.v2i6.34}
}
EUVIMED